| Durga Yarlagadda, MD | |
|
2809 Denny Ave, Pascagoula, MS 39581-5301 | |
| (228) 818-0563 | |
| (228) 818-0519 |
| Full Name | Durga Yarlagadda |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 2809 Denny Ave, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245318732 | NPI | - | NPPES |
| 00113947 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 11573 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Durga Yarlagadda, MD 22 Doctors Dr, Suite C, Ocean Springs, MS 39564 Ph: (228) 818-0563 | Durga Yarlagadda, MD 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 818-0563 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt™ (retigabine) as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.
Repligen Corporation today reported financial results for the quarter and nine-month fiscal year ended December 31, 2011.
Results from the HEBE III study, a prospective, randomised, multicentre trial performed in seven centres in the Netherlands, suggest that the promising effects of erythropoieitin seen in previous smaller studies cannot be confirmed for the improvement of clinical outcome in patients with a first ST-elevation myocardial infarction.
A new study published in the journal Pediatrics on Monday examined the risks of consumption of high-caffeine energy drinks on children and young adults. The study notes that these drinks are linked to an array of serious events like heart palpitations, high blood pressure and even cardiac arrest and death. The risk rises if young adults consuming the drink suffer from chronic diseases or take other medications.
› Verified 3 days ago
Leah Mcmahan, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-818-0563 Fax: 228-818-0519 | |
Walter Risley, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-818-0563 Fax: 228-818-0519 | |
Huntington T Hapworth, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4105 Hospital St Ste 112b, Pascagoula, MS 39581 Phone: 228-938-0700 Fax: 228-938-0705 | |
Darren Cuevas, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5540 Fax: 228-809-1153 | |
Robert Frederick Evans, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Zachary Weldon Greene, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 Fax: 678-553-8152 |